IBDEI07Q ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10153,0)
 ;;=371.20^^72^689^37
 ;;^UTILITY(U,$J,358.3,10153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10153,1,3,0)
 ;;=3^Edema, Cornea
 ;;^UTILITY(U,$J,358.3,10153,1,4,0)
 ;;=4^371.20
 ;;^UTILITY(U,$J,358.3,10153,2)
 ;;=Edema, Cornea^28394
 ;;^UTILITY(U,$J,358.3,10154,0)
 ;;=371.00^^72^689^90
 ;;^UTILITY(U,$J,358.3,10154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10154,1,3,0)
 ;;=3^Opacity, Corneal
 ;;^UTILITY(U,$J,358.3,10154,1,4,0)
 ;;=4^371.00
 ;;^UTILITY(U,$J,358.3,10154,2)
 ;;=Corneal Opacity^28398
 ;;^UTILITY(U,$J,358.3,10155,0)
 ;;=371.43^^72^689^9
 ;;^UTILITY(U,$J,358.3,10155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10155,1,3,0)
 ;;=3^Band Keratopathy
 ;;^UTILITY(U,$J,358.3,10155,1,4,0)
 ;;=4^371.43
 ;;^UTILITY(U,$J,358.3,10155,2)
 ;;=Band Keratopathy^268979
 ;;^UTILITY(U,$J,358.3,10156,0)
 ;;=710.2^^72^689^113
 ;;^UTILITY(U,$J,358.3,10156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10156,1,3,0)
 ;;=3^Sjogren's Disease
 ;;^UTILITY(U,$J,358.3,10156,1,4,0)
 ;;=4^710.2
 ;;^UTILITY(U,$J,358.3,10156,2)
 ;;=Sjogren's Disease^192145
 ;;^UTILITY(U,$J,358.3,10157,0)
 ;;=374.20^^72^689^79
 ;;^UTILITY(U,$J,358.3,10157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10157,1,3,0)
 ;;=3^Lagophthalmos
 ;;^UTILITY(U,$J,358.3,10157,1,4,0)
 ;;=4^374.20
 ;;^UTILITY(U,$J,358.3,10157,2)
 ;;=Lagophthalmos^265452
 ;;^UTILITY(U,$J,358.3,10158,0)
 ;;=372.72^^72^689^49
 ;;^UTILITY(U,$J,358.3,10158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10158,1,3,0)
 ;;=3^Hemorrhage, Conjunctival
 ;;^UTILITY(U,$J,358.3,10158,1,4,0)
 ;;=4^372.72
 ;;^UTILITY(U,$J,358.3,10158,2)
 ;;=Hemorrhage, Conjunctival^27538
 ;;^UTILITY(U,$J,358.3,10159,0)
 ;;=077.8^^72^689^16
 ;;^UTILITY(U,$J,358.3,10159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10159,1,3,0)
 ;;=3^Conjunctivitis, Viral
 ;;^UTILITY(U,$J,358.3,10159,1,4,0)
 ;;=4^077.8
 ;;^UTILITY(U,$J,358.3,10159,2)
 ;;=Conjunctivitis, Viral^88239
 ;;^UTILITY(U,$J,358.3,10160,0)
 ;;=372.54^^72^689^15
 ;;^UTILITY(U,$J,358.3,10160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10160,1,3,0)
 ;;=3^Concretions, Conjunctival
 ;;^UTILITY(U,$J,358.3,10160,1,4,0)
 ;;=4^372.54
 ;;^UTILITY(U,$J,358.3,10160,2)
 ;;=...Concretions, Conjunctival^269038
 ;;^UTILITY(U,$J,358.3,10161,0)
 ;;=930.9^^72^689^45
 ;;^UTILITY(U,$J,358.3,10161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10161,1,3,0)
 ;;=3^Foreign Body, External Eye
 ;;^UTILITY(U,$J,358.3,10161,1,4,0)
 ;;=4^930.9
 ;;^UTILITY(U,$J,358.3,10161,2)
 ;;=Foreign Body, External Eye^275489
 ;;^UTILITY(U,$J,358.3,10162,0)
 ;;=372.51^^72^689^101
 ;;^UTILITY(U,$J,358.3,10162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10162,1,3,0)
 ;;=3^Pinguecula
 ;;^UTILITY(U,$J,358.3,10162,1,4,0)
 ;;=4^372.51
 ;;^UTILITY(U,$J,358.3,10162,2)
 ;;=Pinguecula^265525
 ;;^UTILITY(U,$J,358.3,10163,0)
 ;;=379.00^^72^689^40
 ;;^UTILITY(U,$J,358.3,10163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10163,1,3,0)
 ;;=3^Episcleritis
 ;;^UTILITY(U,$J,358.3,10163,1,4,0)
 ;;=4^379.00
 ;;^UTILITY(U,$J,358.3,10163,2)
 ;;=...^108564
 ;;^UTILITY(U,$J,358.3,10164,0)
 ;;=372.40^^72^689^104
 ;;^UTILITY(U,$J,358.3,10164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10164,1,3,0)
 ;;=3^Pterygium
 ;;^UTILITY(U,$J,358.3,10164,1,4,0)
 ;;=4^372.40
 ;;^UTILITY(U,$J,358.3,10164,2)
 ;;=Pterygium^100819
 ;;^UTILITY(U,$J,358.3,10165,0)
 ;;=694.4^^72^689^96
 ;;^UTILITY(U,$J,358.3,10165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10165,1,3,0)
 ;;=3^Pemphigus
 ;;^UTILITY(U,$J,358.3,10165,1,4,0)
 ;;=4^694.4
 ;;^UTILITY(U,$J,358.3,10165,2)
 ;;=Pemphigus^91124
 ;;^UTILITY(U,$J,358.3,10166,0)
 ;;=224.3^^72^689^10
 ;;^UTILITY(U,$J,358.3,10166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10166,1,3,0)
 ;;=3^Benign Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,10166,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,10166,2)
 ;;=Benign Neoplasm Conjunctiva^267673
 ;;^UTILITY(U,$J,358.3,10167,0)
 ;;=370.40^^72^689^67
 ;;^UTILITY(U,$J,358.3,10167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10167,1,3,0)
 ;;=3^Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,10167,1,4,0)
 ;;=4^370.40
 ;;^UTILITY(U,$J,358.3,10167,2)
 ;;=^66777
 ;;^UTILITY(U,$J,358.3,10168,0)
 ;;=694.5^^72^689^95
 ;;^UTILITY(U,$J,358.3,10168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10168,1,3,0)
 ;;=3^Pemphigoid
 ;;^UTILITY(U,$J,358.3,10168,1,4,0)
 ;;=4^694.5
 ;;^UTILITY(U,$J,358.3,10168,2)
 ;;=Pemphigoid^91108
 ;;^UTILITY(U,$J,358.3,10169,0)
 ;;=364.10^^72^689^54
 ;;^UTILITY(U,$J,358.3,10169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10169,1,3,0)
 ;;=3^Iridocyclitis, Chronic
 ;;^UTILITY(U,$J,358.3,10169,1,4,0)
 ;;=4^364.10
 ;;^UTILITY(U,$J,358.3,10169,2)
 ;;=Iridocyclitis, Chronic^24398
 ;;^UTILITY(U,$J,358.3,10170,0)
 ;;=054.44^^72^689^55
 ;;^UTILITY(U,$J,358.3,10170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10170,1,3,0)
 ;;=3^Iridocyclitis, H Simplex
 ;;^UTILITY(U,$J,358.3,10170,1,4,0)
 ;;=4^054.44
 ;;^UTILITY(U,$J,358.3,10170,2)
 ;;=Iridocyclitis, H Simplex^266565
 ;;^UTILITY(U,$J,358.3,10171,0)
 ;;=053.22^^72^689^56
 ;;^UTILITY(U,$J,358.3,10171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10171,1,3,0)
 ;;=3^Iridocyclitis, H Zoster
 ;;^UTILITY(U,$J,358.3,10171,1,4,0)
 ;;=4^053.22
 ;;^UTILITY(U,$J,358.3,10171,2)
 ;;=Iridocyclitis, H Zoster^266554
 ;;^UTILITY(U,$J,358.3,10172,0)
 ;;=364.42^^72^689^111
 ;;^UTILITY(U,$J,358.3,10172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10172,1,3,0)
 ;;=3^Rubeosis Iridis
 ;;^UTILITY(U,$J,358.3,10172,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,10172,2)
 ;;=Rubeosis Iridis^268716
 ;;^UTILITY(U,$J,358.3,10173,0)
 ;;=364.59^^72^689^59
 ;;^UTILITY(U,$J,358.3,10173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10173,1,3,0)
 ;;=3^Iris Atrophy,Other
 ;;^UTILITY(U,$J,358.3,10173,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,10173,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,10174,0)
 ;;=224.0^^72^689^11
 ;;^UTILITY(U,$J,358.3,10174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10174,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,10174,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,10174,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,10175,0)
 ;;=364.72^^72^689^6
 ;;^UTILITY(U,$J,358.3,10175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10175,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,10175,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,10175,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,10176,0)
 ;;=364.71^^72^689^102
 ;;^UTILITY(U,$J,358.3,10176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10176,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,10176,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,10176,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,10177,0)
 ;;=364.00^^72^689^57
 ;;^UTILITY(U,$J,358.3,10177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10177,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,10177,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,10177,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,10178,0)
 ;;=379.40^^72^689^106
 ;;^UTILITY(U,$J,358.3,10178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10178,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,10178,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,10178,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,10179,0)
 ;;=190.0^^72^689^84
 ;;^UTILITY(U,$J,358.3,10179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10179,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,10179,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,10179,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,10180,0)
 ;;=190.3^^72^689^83
 ;;^UTILITY(U,$J,358.3,10180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10180,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,10180,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,10180,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,10181,0)
 ;;=364.41^^72^689^50
 ;;^UTILITY(U,$J,358.3,10181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10181,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,10181,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,10181,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,10182,0)
 ;;=364.05^^72^689^51
 ;;^UTILITY(U,$J,358.3,10182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10182,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,10182,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,10182,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,10183,0)
 ;;=365.02^^72^689^4
 ;;^UTILITY(U,$J,358.3,10183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10183,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,10183,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,10183,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,10184,0)
 ;;=372.63^^72^689^117
 ;;^UTILITY(U,$J,358.3,10184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10184,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,10184,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,10184,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,10185,0)
 ;;=372.75^^72^689^27
 ;;^UTILITY(U,$J,358.3,10185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10185,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,10185,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,10185,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,10186,0)
 ;;=364.81^^72^689^43
 ;;^UTILITY(U,$J,358.3,10186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10186,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,10186,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,10186,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,10187,0)
 ;;=006.9^^72^689^2
 ;;^UTILITY(U,$J,358.3,10187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10187,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,10187,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,10187,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,10188,0)
 ;;=190.8^^72^689^60
 ;;^UTILITY(U,$J,358.3,10188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10188,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,10188,1,4,0)
 ;;=4^190.8
